A new study warns that rectal cancer deaths are rising at a significantly faster rate than colon cancer among younger Americans, a trend that researchers warn will continue to escalate without a shift in treatment. The study, to be presented at Digestive Disease Week 2026 in Chicago, analyzed Centers for Disease Control and Prevention (CDC) death records from 1999 to 2023 and found that mortality rates for rectal cancer are growing two to three times faster than those for colon cancer among adults aged 20 to 44. The data suggests that for older millennials, specifically those between the ages of 35 and 44, rectal cancer mortality is projected to escalate through 2035.
Diagnostic Delays and Aggressive Cases
The study highlights a concerning trend of diagnostic delays among younger patients, often leading to more advanced and aggressive stages of disease. Researchers note that rectal cancer is no longer considered predominantly a disease of older adults, with Hispanic adults and residents of Western states experiencing the steepest increases in rectal cancer deaths. The widening mortality gap between rectal and colon cancer across all demographics raises urgent concerns about treatment and prevention strategies.
Microbiome and Environmental Factors
Scientists are increasingly focusing on the gut microbiome as a potential key actor behind the rise in colorectal cancers among younger patients. While genetics play a role in about 20% of cases, the vast majority remain unexplained, leading researchers to suspect environmental factors or changes. Advocates emphasize the importance of early diagnostic testing, especially for young adults with a family history of colorectal cancer, as preventive testing is not regularly recommended until age 45.
Treatment Challenges
Despite advances in cancer treatment, colorectal cancer has become more lethal and is now the top cancer killer among people under 50. Even with more aggressive chemotherapy and surgery, outcomes for younger patients are not necessarily better. This underscores the need for further research and targeted interventions to address the rising rates of rectal cancer in younger populations.